大成生化科技(00809)拟“10合1”进行股份合并及更改每手买卖单位

Group 1 - The company, Da Cheng Biochemical Technology (00809), announced a proposal for a share consolidation [1] - The consolidation will involve merging every 10 existing shares with a par value of HKD 0.10 into 1 consolidated share with a par value of HKD 1.00 [1] - The same consolidation will apply to the existing convertible preference shares, where every 10 shares will be merged into 1 consolidated convertible preference share [1] Group 2 - Following the consolidation, the trading unit on the Hong Kong Stock Exchange will change from 2,000 existing shares to 10,000 consolidated shares [1]